The molecular basis of immuno-radiotherapy

References

• (No authors listed). 2010. Ipilimumab. Drugs R D. 10(2):97–110.
   PubMedGoogle Scholar
• Abdel-Wahab Z, Dar MM, Hester D, Vervaert C, Gangavalli R, Barber J, Darrow TL, Seigler HF. 1996. Effect of irradiation on cytokine production, MHC antigen expression, and vaccine potential of interleukin-2 and interferon-gamma gene-modified melanoma cells. Cell Immunol. 171(2):246–254.
   PubMed Web of Science ®Google Scholar
• Ablasser A, Schmid-Burgk JL, Hemmerling I, Horvath GL, Schmidt T, Latz E, Hornung V. 2013. Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP. Nature. 503(7477):530–534.
   PubMed Web of Science ®Google Scholar
• Adjemian S, Oltean T, Martens S, Wiernicki B, Goossens V, Vanden Berghe T, Cappe B, Ladik M, Riquet FB, Heyndrickx L, et al. 2020. Ionizing radiation results in a mixture of cellular outcomes including mitotic catastrophe, senescence, methuosis, and iron-dependent cell death. Cell Death Dis. 11(11):1003.
   PubMed Web of Science ®Google Scholar
• Ahmed KM, Li JJ. 2008. NF-kappa B-mediated adaptive resistance to ionizing radiation. Free Radic Biol Med. 44(1):1–13.
   PubMed Web of Science ®Google Scholar
• Amu S, Saunders SP, Kronenberg M, Mangan NE, Atzberger A, Fallon PG. 2010. Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model. J Allergy Clin Immunol. 125(5):1114–1124.e8.
   PubMed Web of Science ®Google Scholar
• Arab S, Hadjati J. 2019. Adenosine blockage in tumor microenvironment and improvement of cancer immunotherapy. Immune Netw. 19(4):e23.
   PubMed Web of Science ®Google Scholar
• Aymeric L, Apetoh L, Ghiringhelli F, Tesniere A, Martins I, Kroemer G, Smyth MJ, Zitvogel L. 2010. Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity. Cancer Res. 70(3):855–858.
   PubMed Web of Science ®Google Scholar
• Barrera L, Montes-Servín E, Hernandez-Martinez JM, García-Vicente MLÁ, Montes-Servín E, Herrera-Martínez M, Crispín JC, Borbolla-Escoboza JR, Arrieta O. 2017. CD47 overexpression is associated with decreased neutrophil apoptosis/phagocytosis and poor prognosis in non-small-cell lung cancer patients. Br J Cancer. 117(3):385–397.
   PubMed Web of Science ®Google Scholar
• Bashford EF, Murray JA, Cramer W. 1907. The natural and induced resistance of mice to the growth of cancer. Proc Royal Soc B 79:164–187.
   Google Scholar
• Bernstein MB, Garnett CT, Zhang H, Velcich A, Wattenberg MM, Gameiro SR, Kalnicki S, Hodge JW, Guha C. 2014. Radiation-induced modulation of costimulatory and coinhibitory T-cell signaling molecules on human prostate carcinoma cells promotes productive antitumor immune interactions. Cancer Biother Radiopharm. 29(4):153–161.
   PubMed Web of Science ®Google Scholar
• Berzaghi R, Tornaas S, Lode K, Hellevik T, Martinez-Zubiaurre I. 2021. Ionizing radiation curtails immunosuppressive effects from cancer-associated fibroblasts on dendritic cells. Front Immunol. 12:662594.
   PubMed Web of Science ®Google Scholar
• Boussiotis VA, Chatterjee P, Li L. 2014. Biochemical signaling of PD-1 on T cells and its functional implications. Cancer J. 20(4):265–271.
   PubMed Web of Science ®Google Scholar
• Brunner C, Seiderer J, Schlamp A, Bidlingmaier M, Eigler A, Haimerl W, Lehr HA, Krieg AM, Hartmann G, Endres S. 2000. Enhanced dendritic cell maturation by TNF-alpha or cytidine-phosphate-guanosine DNA drives T cell activation in vitro and therapeutic anti-tumor immune responses in vivo. J Immunol. 165(11):6278–6286.
   PubMed Web of Science ®Google Scholar
• Burdick CG. 1937. William Bradley Coley 1862-1936. Ann Surg. 105(1):152–155.
   PubMedGoogle Scholar
• Burnette BC, Liang H, Lee Y, Chlewicki L, Khodarev NN, Weichselbaum RR, Fu YX, Auh SL. 2011. The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity. Cancer Res. 71(7):2488–2496.
   PubMed Web of Science ®Google Scholar
• Bursuker I, Pearce MT. 1990. Production of interferon-gamma by in vivo tumor-sensitized T cells: association with active antitumor immunity. J Interferon Res. 10(1):1–11.
   PubMedGoogle Scholar
• Candas-Green D, Xie B, Huang J, Fan M, Wang A, Menaa C, Zhang Y, Zhang L, Jing D, Azghadi S, et al. 2020. Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells. Nat Commun. 11(1):4591.
   PubMed Web of Science ®Google Scholar
• Carter NA, Vasconcellos R, Rosser EC, Tulone C, Muñoz-Suano A, Kamanaka M, Ehrenstein MR, Flavell RA, Mauri C. 2011. Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J Immunol. 186(10):5569–5579.
   PubMed Web of Science ®Google Scholar
• Caux C, Massacrier C, Vanbervliet B, Barthelemy C, Liu YJ, Banchereau J. 1994. Interleukin 10 inhibits T cell alloreaction induced by human dendritic cells. Int Immunol. 6(8):1177–1185.
   PubMed Web of Science ®Google Scholar
• Cerwenka A, Lanier LL. 2018. Natural killers join the fight against cancer. Science. 359(6383):1460–1461.
   PubMed Web of Science ®Google Scholar
• Chakraborty M, Abrams SI, Camphausen K, Liu K, Scott T, Coleman CN, Hodge JW. 2003. Irradiation of tumor cells up-regulates Fas and enhances CTL lytic activity and CTL adoptive immunotherapy. J Immunol. 170(12):6338–6347.
   PubMed Web of Science ®Google Scholar
• Chakraborty M, Abrams SI, Coleman CN, Camphausen K, Schlom J, Hodge JW. 2004. External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing. Cancer Res. 64(12):4328–4337.
   PubMed Web of Science ®Google Scholar
• Chang E, Pelosof L, Lemery S, Gong Y, Goldberg KB, Farrell AT, Keegan P, Veeraraghavan J, Wei G, Blumenthal GM, et al. 2021. Systematic review of PD-1/PD-L1 inhibitors in oncology: from personalized medicine to public health. Oncologist. 26(10):e1786–e1799.
   PubMed Web of Science ®Google Scholar
• Chapuis AG, Afanasiev OK, Iyer JG, Paulson KG, Parvathaneni U, Hwang JH, Lai I, Roberts IM, Sloan HL, Bhatia S, et al. 2014. Regression of metastatic Merkel cell carcinoma following transfer of polyomavirus-specific T cells and therapies capable of re-inducing HLA class-I. Cancer Immunol Res. 2(1):27–36.
   PubMed Web of Science ®Google Scholar
• Chen W. 2011. Tregs in immunotherapy: opportunities and challenges. Immunotherapy. 3(8):911–914.
   PubMed Web of Science ®Google Scholar
• Chow Z, Banerjee A, Hickey MJ. 2015. Controlling the fire–tissue-specific mechanisms of effector regulatory T-cell homing. Immunol Cell Biol. 93(4):355–363.
   PubMed Web of Science ®Google Scholar
• Couper KN, Blount DG, Riley EM. 2008. IL-10: the master regulator of immunity to infection. J Immunol. 180(9):5771–5777.
   PubMed Web of Science ®Google Scholar
• Dancea HC, Shareef MM, Ahmed MM. 2009. Role of radiation-induced TGF-beta signaling in cancer therapy. Mol Cell Pharmacol. 1(1):44–56.
   PubMedGoogle Scholar
• Das M, Zhu C, Kuchroo VK. 2017. Tim-3 and its role in regulating anti-tumor immunity. Immunol Rev. 276(1):97–111.
   PubMed Web of Science ®Google Scholar
• Demaria S, Kawashima N, Yang AM, Devitt ML, Babb JS, Allison JP, Formenti SC. 2005. Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer. Clin Cancer Res. 11(2):728–734.
   PubMed Web of Science ®Google Scholar
• Deng L, Liang H, Burnette B, Beckett M, Darga T, Weichselbaum RR, Fu YX. 2014. Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice. J Clin Invest. 124(2):687–695.
   PubMed Web of Science ®Google Scholar
• Derer A, Spiljar M, Bäumler M, Hecht M, Fietkau R, Frey B, Gaipl US. 2016. Chemoradiation increases PD-L1 expression in certain melanoma and glioblastoma cells. Front Immunol. 7:610.
   PubMed Web of Science ®Google Scholar
• Dovedi SJ, Illidge TM. 2015. The antitumor immune response generated by fractionated radiation therapy may be limited by tumor cell adaptive resistance and can be circumvented by PD-L1 blockade. Oncoimmunology. 4(7):e1016709.
   PubMed Web of Science ®Google Scholar
• Eckert F, Schaedle P, Zips D, Schmid-Horch B, Rammensee HG, Gani C, Gouttefangeas C. 2018. Impact of curative radiotherapy on the immune status of patients with localized prostate cancer. Oncoimmunology. 7(11):e1496881.
   PubMed Web of Science ®Google Scholar
• Ehrlich P. 1909. Über den jetzigen stand der karzinomforschung [the present state of carcinoma research. Ned Tijdschr Geneeskd. 5:273–290.
   Google Scholar
• Eikawa S, Ohue Y, Kitaoka K, Aji T, Uenaka A, Oka M, Nakayama E. 2010. Enrichment of Foxp3+ CD4 regulatory T cells in migrated T cells to IL-6- and IL-8-expressing tumors through predominant induction of CXCR1 by IL-6. J Immunol. 185(11):6734–6740.
   PubMed Web of Science ®Google Scholar
• Eriksson D, Stigbrand T. 2010. Radiation-induced cell death mechanisms. Tumour Biol. 31(4):363–372.
   PubMedGoogle Scholar
• Esebanmen GE, Langridge WHR. 2017. The role of TGF-beta signaling in dendritic cell tolerance. Immunol Res. 65(5):987–994.
   PubMed Web of Science ®Google Scholar
• Francisco LM, Sage PT, Sharpe AH. 2010. The PD-1 pathway in tolerance and autoimmunity. Immunol Rev. 236:219–242.
   PubMed Web of Science ®Google Scholar
• Frey B, Rückert M, Weber J, Mayr X, Derer A, Lotter M, Bert C, Rödel F, Fietkau R, Gaipl US. 2017. Hypofractionated irradiation has immune stimulatory potential and induces a timely restricted infiltration of immune cells in colon cancer tumors. Front Immunol. 8:231.
   PubMed Web of Science ®Google Scholar
• Fu W, Li J, Zhang W, Li P. 2017. High expression of CD47 predicts adverse prognosis in Chinese patients and suppresses immune response in melanoma. Biomed Pharmacother. 93:1190–1196.
   PubMed Web of Science ®Google Scholar
• Ganss R, Ryschich E, Klar E, Arnold B, Hämmerling GJ. 2002. Combination of T-cell therapy and trigger of inflammation induces remodeling of the vasculature and tumor eradication. Cancer Res. 62(5):1462–1470.
   PubMed Web of Science ®Google Scholar
• Garnett CT, Palena C, Chakraborty M, Chakarborty M, Tsang K-Y, Schlom J, Hodge JW. 2004. Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes. Cancer Res. 64(21):7985–7994.
   PubMed Web of Science ®Google Scholar
• Gaugler MH, Squiban C, van der Meeren A, Bertho JM, Vandamme M, Mouthon MA. 1997. Late and persistent up-regulation of intercellular adhesion molecule-1 (ICAM-1) expression by ionizing radiation in human endothelial cells in vitro. Int J Radiat Biol. 72(2):201–209.
   PubMed Web of Science ®Google Scholar
• Gerber SA, Sedlacek AL, Cron KR, Murphy SP, Frelinger JG, Lord EM. 2013. IFN-γ mediates the antitumor effects of radiation therapy in a murine colon tumor. Am J Pathol. 182(6):2345–2354.
   PubMed Web of Science ®Google Scholar
• Gewirtz DA, Alotaibi M, Yakovlev VA, Povirk LF. 2016. Tumor cell recovery from senescence induced by radiation with PARP inhibition. Radiat Res. 186(4):327–332.
   PubMed Web of Science ®Google Scholar
• Ghiringhelli F, Apetoh L, Tesniere A, Aymeric L, Ma Y, Ortiz C, Vermaelen K, Panaretakis T, Mignot G, Ullrich E, et al. 2009. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med. 15(10):1170–1178.
   PubMed Web of Science ®Google Scholar
• Giatromanolaki A, Kouroupi M, Pouliliou S, Mitrakas A, Hasan F, Pappa A, Koukourakis MI. 2020. Ectonucleotidase CD73 and CD39 expression in non-small cell lung cancer relates to hypoxia and immunosuppressive pathways. Life Sci. 259:118389.
   PubMed Web of Science ®Google Scholar
• Goedegebuure RSA, Kleibeuker EA, Buffa FM, Castricum KCM, Haider S, Schulkens IA, Ten Kroode L, van den Berg J, Jacobs MAJM, van Berkel AM, et al. 2021. Interferon- and STING-independent induction of type I interferon stimulated genes during fractionated irradiation. J Exp Clin Cancer Res. 40(1):161.
   PubMed Web of Science ®Google Scholar
• Golstein P, Griffiths GM. 2018. An early history of T cell-mediated cytotoxicity. Nat Rev Immunol. 18(8):527–535.
   PubMed Web of Science ®Google Scholar
• Gooden MJ, de Bock GH, Leffers N, Daemen T, Nijman HW. 2011. The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis. Br J Cancer. 105(1):93–103.
   PubMed Web of Science ®Google Scholar
• Goodfellow PN, Jones EA, Van Heyningen V, Solomon E, Bobrow M, Miggiano V, Bodmer WF. 1975. The beta2-microglobulin gene is on chromosome 15 and not in the HL-A region. Nature. 254(5497):267–269.
   PubMed Web of Science ®Google Scholar
• Gorski DH, Beckett MA, Jaskowiak NT, Calvin DP, Mauceri HJ, Salloum RM, Seetharam S, Koons A, Hari DM, Kufe DW, et al. 1999. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res. 59(14):3374–3378.
   PubMed Web of Science ®Google Scholar
• Greenwald RJ, Freeman GJ, Sharpe AH. 2005. The B7 family revisited. Annu Rev Immunol. 23:515–548.
   PubMed Web of Science ®Google Scholar
• Grover S, Bvochora-Nsingo M, Yeager A, Chiyapo S, Bhatia R, MacDuffie E, Puri P, Balang D, Ratcliffe S, Narasimhamurthy M, et al. 2018. Impact of human immunodeficiency virus infection on survival and acute toxicities from chemoradiation therapy for cervical cancer patients in a limited-resource setting. Int J Radiat Oncol Biol Phys. 101(1):201–210.
   PubMed Web of Science ®Google Scholar
• Gupta A, Probst HC, Vuong V, Landshammer A, Muth S, Yagita H, Schwendener R, Pruschy M, Knuth A, van den Broek M. 2012. Radiotherapy promotes tumor-specific effector CD8+ T cells via dendritic cell activation. J Immunol. 189(2):558–566.
   PubMed Web of Science ®Google Scholar
• Haeggblom L, Nordfors C, Tertipis N, Bersani C, Ramqvist T, Näsman A, Dalianis T. 2017. Effects of irradiation on human leukocyte antigen class I expression in human papillomavirus positive and negative base of tongue and mobile tongue squamous cell carcinoma cell lines. Int J Oncol. 50(4):1423–1430.
   PubMed Web of Science ®Google Scholar
• Hagn M, Schwesinger E, Ebel V, Sontheimer K, Maier J, Beyer T, Syrovets T, Laumonnier Y, Fabricius D, Simmet T, et al. 2009. Human B cells secrete granzyme B when recognizing viral antigens in the context of the acute phase cytokine IL-21. J Immunol. 183(3):1838–1845.
   PubMed Web of Science ®Google Scholar
• Hahne M, Renno T, Schroeter M, Irmler M, French L, Bornard T, MacDonald HR, Tschopp J. 1996. Activated B cells express functional Fas ligand. Eur J Immunol. 26(3):721–724.
   PubMed Web of Science ®Google Scholar
• Han SK, Song JY, Yun YS, Yi SY. 2002. Gamma irradiation-reduced IFN-gamma expression, STAT1 signals, and cell-mediated immunity. J Biochem Mol Biol. 35(6):583–589.
   PubMedGoogle Scholar
• Hareyama M, Imai K, Kubo K, Takahashi H, Koshiba H, Hinoda Y, Shidou M, Oouchi A, Yachi A, Morita K. 1991. Effect of radiation on the expression of carcinoembryonic antigen of human gastric adenocarcinoma cells. Cancer. 67(9):2269–2274.
   PubMed Web of Science ®Google Scholar
• Harisiadis L, Kopelson G, Chang CH. 1977. Lymphopenia caused by cranial irradiation in children receiving craniospinal radiotherapy. Cancer. 40(3):1102–1108.
   PubMed Web of Science ®Google Scholar
• Harris JE, Ryan L, Hoover HC, Jr, Stuart RK, Oken MM, Benson AB, 3rd, Mansour E, Haller DG, Manola J, Hanna MG. Jr. 2000. Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: eastern cooperative oncology group study E5283. J Clin Oncol. 18(1):148–157.
   PubMed Web of Science ®Google Scholar
• Hauser SH, Calorini L, Wazer DE, Gattoni-Celli S. 1993. Radiation-enhanced expression of major histocompatibility complex class I antigen H-2Db in B16 melanoma cells. Cancer Res. 53(8):1952–1955.
   PubMed Web of Science ®Google Scholar
• Heckmann M, Douwes K, Peter R, Degitz K. 1998. Vascular activation of adhesion molecule mRNA and cell surface expression by ionizing radiation. Exp Cell Res. 238(1):148–154.
   PubMed Web of Science ®Google Scholar
• Heier HE, Christensen I, Froland SS, Engeset A. 1975. Early and late effects of irradiation for seminoma testis on the number of blood lymphocytes and their B and T subpopulations. Lymphology. 8(3):69–74.
   PubMed Web of Science ®Google Scholar
• Hellevik T, Martinez-Zubiaurre I. 2014. Radiotherapy and the tumor stroma: the importance of dose and fractionation. Front Oncol. 4:1.
   PubMedGoogle Scholar
• Hernandez-Segura A, Nehme J, Demaria M. 2018. Hallmarks of cellular senescence. Trends Cell Biol. 28(6):436–453.
   PubMed Web of Science ®Google Scholar
• Horton JK, Siamakpour-Reihani S, Lee CT, Zhou Y, Chen W, Geradts J, Fels DR, Hoang P, Ashcraft KA, Groth J, et al. 2015. FAS death receptor: a breast cancer subtype-specific radiation response biomarker and potential therapeutic target. Radiat Res. 184(5):456–469.
   PubMed Web of Science ®Google Scholar
• Horvath CM. 2004. The Jak-STAT pathway stimulated by interferon alpha or interferon beta. Sci STKE. 2004(260):tr10.
   PubMedGoogle Scholar
• Huang Y, Snuderl M, Jain RK. 2011. Polarization of tumor-associated macrophages: a novel strategy for vascular normalization and antitumor immunity. Cancer Cell. 19(1):1–2.
   PubMed Web of Science ®Google Scholar
• Huang J, Wang QJ, Yang S, Li YF, El-Gamil M, Rosenberg SA, Robbins PF. 2011. Irradiation enhances human T-cell function by upregulating CD70 expression on antigen-presenting cells in vitro. J Immunother. 34(4):327–335.
   PubMed Web of Science ®Google Scholar
• Huang C, Zhu HX, Yao Y, Bian ZH, Zheng YJ, Li L, Moutsopoulos HM, Gershwin ME, Lian ZX. 2019. Immune checkpoint molecules. Possible future therapeutic implications in autoimmune diseases. J Autoimmun. 104:102333.
   PubMed Web of Science ®Google Scholar
• Ishikawa F, Nakano H, Seo A, Okada Y, Torihata H, Tanaka Y, Uchida T, Miyake H, Kakiuchi T. 2002. Irradiation up-regulates CD80 expression through induction of tumour necrosis factor-alpha and CD40 ligand expression on B lymphoma cells. Immunology. 106(3):354–362.
   PubMed Web of Science ®Google Scholar
• Ivanov VN, Zhou H, Hei TK. 2007. Sequential treatment by ionizing radiation and sodium arsenite dramatically accelerates TRAIL-mediated apoptosis of human melanoma cells. Cancer Res. 67(11):5397–5407.
   PubMed Web of Science ®Google Scholar
• Jagodinsky JC, Jin WJ, Bates AM, Hernandez R, Grudzinski JJ, Marsh IR, Chakravarty I, Arthur IS, Zangl LM, Brown RJ, et al. 2021. Temporal analysis of type 1 interferon activation in tumor cells following external beam radiotherapy or targeted radionuclide therapy. Theranostics. 11(13):6120–6137.
   PubMed Web of Science ®Google Scholar
• Jiang N, Xie B, Xiao W, Fan M, Xu S, Duan Y, Hamsafar Y, Evans AC, Huang J, Zhou W, et al. 2022. Fatty acid oxidation fuels glioblastoma radioresistance with CD47-mediated immune evasion. Nat Commun. 13(1):1511.
   PubMed Web of Science ®Google Scholar
• Jobling MF, Mott JD, Finnegan MT, Jurukovski V, Erickson AC, Walian PJ, Taylor SE, Ledbetter S, Lawrence CM, Rifkin DB, et al. 2006. Isoform-specific activation of latent transforming growth factor beta (LTGF-beta) by reactive oxygen species. Radiat Res. 166(6):839–848.
   PubMed Web of Science ®Google Scholar
• Jurin M, Suit HD. 1972. In vivo and in vitro studies of the influence of the immune status of C3Hf-Bu mice on the effectiveness of local irradiation of a methylcholanthrene-induced fibrosarcoma. Cancer Res. 32(10):2201–2211.
   PubMed Web of Science ®Google Scholar
• Kaklamanis L, Leek R, Koukourakis M, Gatter KC, Harris AL. 1995. Loss of transporter in antigen processing 1 transport protein and major histocompatibility complex class I molecules in metastatic versus primary breast cancer. Cancer Res. 55(22):5191–5194.
   PubMed Web of Science ®Google Scholar
• Keir ME, Liang SC, Guleria I, Latchman YE, Qipo A, Albacker LA, Koulmanda M, Freeman GJ, Sayegh MH, Sharpe AH. 2006. Tissue expression of PD-L1 mediates peripheral T cell tolerance. J Exp Med. 203(4):883–895.
   PubMed Web of Science ®Google Scholar
• Keller AM, Schildknecht A, Xiao Y, van den Broek M, Borst J. 2008. Expression of costimulatory ligand CD70 on steady-state dendritic cells breaks CD8+ T cell tolerance and permits effective immunity. Immunity. 29(6):934–946.
   PubMed Web of Science ®Google Scholar
• Kellock TH, Chambers H, Russ S. 1922. An attempt to produce immunity to malignant disease in man. Lancet. 1:217–219.
   Google Scholar
• Kim TD, Li G, Song KS, Kim JM, Kim JS, Kim JS, Yun EJ, Park JI, Park HD, Hwang BD, et al. 2009. Radiation-induced thymidine phosphorylase upregulation in rectal cancer is mediated by tumor-associated macrophages by monocyte chemoattractant protein-1 from cancer cells. Int J Radiat Oncol Biol Phys. 73(3):853–860.
   PubMed Web of Science ®Google Scholar
• Klein B, Loven D, Lurie H, Rakowsky E, Nyska A, Levin I, Klein T. 1994. The effect of irradiation on expression of HLA class I antigens in human brain tumors in culture. J Neurosurg. 80(6):1074–1077.
   PubMed Web of Science ®Google Scholar
• Klug F, Prakash H, Huber PE, Seibel T, Bender N, Halama N, Pfirschke C, Voss RH, Timke C, Umansky L, et al. 2013. Low-dose irradiation programs macrophage differentiation to an iNOS+/M1 phenotype that orchestrates effective T cell immunotherapy. Cancer Cell. 24(5):589–602.
   PubMed Web of Science ®Google Scholar
• Koebel CM, Vermi W, Swann JB, Zerafa N, Rodig SJ, Old LJ, Smyth MJ, Schreiber RD. 2007. Adaptive immunity maintains occult cancer in an equilibrium state. Nature. 450(7171):903–907.
   PubMed Web of Science ®Google Scholar
• Könemann S, Bölling T, Malath J, Kolkmeyer A, Janke K, Riesenbeck D, Hesselmann S, Diallo R, Vormoor J, Willich N, et al. 2003. Time- and dose-dependent changes of intracellular cytokine and cytokine receptor profile of Ewing tumour subpopulations under the influence of ionizing radiation. Int J Radiat Biol. 79(11):897–909.
   PubMed Web of Science ®Google Scholar
• Koukourakis GV, Baksevanis CN, Zambatis H, Gritzapis A, Maltezos E, Simopoulos C, Koukourakis MI. 2009. Amifostine enhances recovery and expansion of peripheral FAS/CD95+ T- and NK-cell subpopulations during radiotherapy of patients with head-neck cancer. Int J Radiat Biol. 85(1):96–104.
   PubMed Web of Science ®Google Scholar
• Koukourakis MI, Giatromanolaki A. 2020. Tumor microenvironment, immune response and post-radiotherapy tumor clearance. Clin Transl Oncol. 22(12):2196–2205.
   PubMed Web of Science ®Google Scholar
• Koukourakis MI, Giatromanolaki A. 2021. Lymphopenia and intratumoral lymphocytic balance in the era of cancer immuno-radiotherapy. Crit Rev Oncol Hematol. 159:103226.
   PubMed Web of Science ®Google Scholar
• Koukourakis MI, Giatromanolaki A. 2022. Tumor draining lymph nodes, immune response, and radiotherapy: towards a revisal of therapeutic principles. Biochim Biophys Acta Rev Cancer. 1877(3):188704.
   PubMed Web of Science ®Google Scholar
• Koukourakis MI, Giatromanolaki A, Harris AL, Sivridis E. 2006. Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma. Cancer Res. 66(2):632–637.
   PubMed Web of Science ®Google Scholar
• Koukourakis MI, Giatromanolaki A, Tsakmaki V, Danielidis V, Sivridis E. 2012. Cancer stem cell phenotype relates to radio-chemotherapy outcome in locally advanced squamous cell head-neck cancer. Br J Cancer. 106(5):846–853.
   PubMed Web of Science ®Google Scholar
• Koukourakis IM, Koukourakis MI. 2021. Combining the past and present to advance immuno-radiotherapy of cancer. Int Rev Immunol. 12:1–17.
   Google Scholar
• Koukourakis MI, Mitrakas AG, Giatromanolaki A. 2016. Therapeutic interactions of autophagy with radiation and temozolomide in glioblastoma: evidence and issues to resolve. Br J Cancer. 114(5):485–496.
   PubMed Web of Science ®Google Scholar
• Lambert LE, Paulnock DM. 1987. Modulation of macrophage function by gamma-irradiation. Acquisition of the primed cell intermediate stage of the macrophage tumoricidal activation pathway. J Immunol. 139(8):2834–2841.
   PubMed Web of Science ®Google Scholar
• Lau LL, Jamieson BD, Somasundaram T, Ahmed R. 1994. Cytotoxic T-cell memory without antigen. Nature. 369(6482):648–652.
   PubMed Web of Science ®Google Scholar
• Lederman M. 1981. The early history of radiotherapy: 1895–1939. Int J Radiat Oncol Biol Phys. 7(5):639–648.
   PubMed Web of Science ®Google Scholar
• Letendre P, Monga V, Milhem M, Zakharia Y. 2017. Ipilimumab: from preclinical development to future clinical perspectives in melanoma. Future Oncol. 13(7):625–636.
   PubMed Web of Science ®Google Scholar
• Lhuillier C, Rudqvist NP, Yamazaki T, Zhang T, Charpentier M, Galluzzi L, Dephoure N, Clement CC, Santambrogio L, Zhou XK, et al. 2021. Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control. J Clin Invest. 131(5):e138740.
   PubMed Web of Science ®Google Scholar
• Liang H, Deng L, Chmura S, Burnette B, Liadis N, Darga T, Beckett MA, Lingen MW, Witt M, Weichselbaum RR, et al. 2013. Radiation-induced equilibrium is a balance between tumor cell proliferation and T cell-mediated killing. J Immunol. 190(11):5874–5881.
   PubMed Web of Science ®Google Scholar
• Liu X, Shin N, Koblish HK, Yang G, Wang Q, Wang K, Leffet L, Hansbury MJ, Thomas B, Rupar M, et al. 2010. Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity. Blood. 115(17):3520–3530.
   PubMed Web of Science ®Google Scholar
• Loke P, Allison JP. 2003. PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells. Proc Natl Acad Sci U S A. 100(9):5336–5341.
   PubMed Web of Science ®Google Scholar
• Ludewig B, Graf D, Gelderblom HR, Becker Y, Kroczek RA, Pauli G. 1995. Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40-ligand) and TNF-alpha, but strongly enhanced by interleukin-10. Eur J Immunol. 25(7):1943–1950.
   PubMed Web of Science ®Google Scholar
• Lugade AA, Moran JP, Gerber SA, Rose RC, Frelinger JG, Lord EM. 2005. Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor. J Immunol. 174(12):7516–7523.
   PubMed Web of Science ®Google Scholar
• Lugade AA, Sorensen EW, Gerber SA, Moran JP, Frelinger JG, Lord EM. 2008. Radiation-induced IFN-gamma production within the tumor microenvironment influences antitumor immunity. J Immunol. 180(5):3132–3139.
   PubMed Web of Science ®Google Scholar
• Luke JJ, Onderdonk BE, Bhave SR, Karrison T, Lemons JM, Chang P, Zha Y, Carll T, Krausz T, Huang L, et al. 2020. Improved survival associated with local tumor response following multisite radiotherapy and pembrolizumab: secondary analysis of a phase I trial. Clin Cancer Res. 26(24):6437–6444.
   PubMed Web of Science ®Google Scholar
• Lundy SK. 2009. Killer B lymphocytes: the evidence and the potential. Inflamm Res. 58(7):345–357.
   PubMed Web of Science ®Google Scholar
• Lussier DM, Alspach E, Ward JP, Miceli AP, Runci D, White JM, Mpoy C, Arthur CD, Kohlmiller HN, Jacks T, et al. 2021. Radiation-induced neoantigens broaden the immunotherapeutic window of cancers with low mutational loads. Proc Natl Acad Sci USA. 118(24):e2102611118.
   PubMed Web of Science ®Google Scholar
• Ma JL, Jin L, Li YD, He CC, Guo XJ, Liu R, Yang YY, Han SX. 2014. The intensity of radiotherapy-elicited immune response is associated with esophageal cancer clearance. J Immunol Res. 2014:794249.
   PubMed Web of Science ®Google Scholar
• Manyam BV, Garsa AA, Chin RI, Reddy CA, Gastman B, Thorstad W, Yom SS, Nussenbaum B, Wang SJ, Vidimos AT, et al. 2017. A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck. Cancer. 123(11):2054–2060.
   PubMed Web of Science ®Google Scholar
• Marin-Acevedo JA, Kimbrough EO, Lou Y. 2021. Next generation of immune checkpoint inhibitors and beyond. J Hematol Oncol. 14(1):45.
   PubMed Web of Science ®Google Scholar
• Martin D, Balermpas P, Fokas E, Rödel C, Yildirim M. 2017. Are there HIV-specific differences for anal cancer patients treated with standard chemoradiotherapy in the era of combined antiretroviral therapy? Clin Oncol (R Coll Radiol). 29(4):248–255.
   PubMed Web of Science ®Google Scholar
• Martinet L, Smyth MJ. 2015. Balancing natural killer cell activation through paired receptors. Nat Rev Immunol. 15(4):243–254.
   PubMed Web of Science ®Google Scholar
• Martinotti S, Patrone M, Ranzato E. 2015. Emerging roles for HMGB1 protein in immunity, inflammation, and cancer. Immunotargets Ther. 4:101–109.
   PubMed Web of Science ®Google Scholar
• Matlung HL, Szilagyi K, Barclay NA, van den Berg TK. 2017. The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer. Immunol Rev. 276(1):145–164.
   PubMed Web of Science ®Google Scholar
• Matsumura S, Demaria S. 2010. Up-regulation of the pro-inflammatory chemokine CXCL16 is a common response of tumor cells to ionizing radiation. Radiat Res. 173(4):418–425.
   PubMed Web of Science ®Google Scholar
• Matsumura S, Wang B, Kawashima N, Braunstein S, Badura M, Cameron TO, Babb JS, Schneider RJ, Formenti SC, Dustin ML, et al. 2008. Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells. J Immunol. 181(5):3099–3107.
   PubMed Web of Science ®Google Scholar
• McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, Gray R, Mannu G, Peto R, Whelan T, EBCTCG (Early Breast Cancer Trialists’ Collaborative Group), et al. 2014. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomized trials. Lancet. 383(9935):2127–2135.
   PubMed Web of Science ®Google Scholar
• Ménétrier-Caux C, Ray-Coquard I, Blay JY, Caux C. 2019. Lymphopenia in cancer patients and its effects on response to immunotherapy: an opportunity for combination with cytokines? J Immunother Cancer. 7(1):85.
   PubMedGoogle Scholar
• Micheau O, Solary E, Hammann A, Martin F, Dimanche-Boitrel MT. 1997. Sensitization of cancer cells treated with cytotoxic drugs to fas-mediated cytotoxicity. J Natl Cancer Inst. 89(11):783–789.
   PubMedGoogle Scholar
• Milanovic M, Fan DNY, Belenki D, Däbritz JHM, Zhao Z, Yu Y, Dörr JR, Dimitrova L, Lenze D, Monteiro Barbosa IA, et al. 2018. Senescence-associated reprogramming promotes cancer stemness. Nature. 553(7686):96–100.
   PubMed Web of Science ®Google Scholar
• Mimura K, Teh JL, Okayama H, Shiraishi K, Kua LF, Koh V, Smoot DT, Ashktorab H, Oike T, Suzuki Y, et al. 2018. PD-L1 expression is mainly regulated by interferon gamma associated with JAK-STAT pathway in gastric cancer. Cancer Sci. 109(1):43–53.
   PubMed Web of Science ®Google Scholar
• Morel A, Fernandez N, de La Coste A, Haddada H, Viguier M, Polla BS, Antoine B, Kahn A. 1998. Gamma-ray irradiation induces B7.1 costimulatory molecule neoexpression in various murine tumor cells. Cancer Immunol Immunother. 46(5):277–282.
   PubMed Web of Science ®Google Scholar
• Naumov GN, Folkman J, Straume O. 2009. Tumor dormancy due to failure of angiogenesis: role of the microenvironment. Clin Exp Metastasis. 26(1):51–60.
   PubMed Web of Science ®Google Scholar
• Nishioka A, Ogawa Y, Kubonishi I, Kataoka S, Hamada N, Terashima M, Inomata T, Yoshida S. 1999. An augmentation of Fas (CD95/APO-1) antigen induced by radiation: flow cytometry analysis of lymphoma and leukemia cell lines. Int J Mol Med. 3(3):275–278.
   PubMed Web of Science ®Google Scholar
• Ogawa Y, Nishioka A, Hamada N, Terashima M, Inomata T, Yoshida S, Seguchi H, Kishimoto S. 1997. Expression of fas (CD95/APO-1) antigen induced by radiation therapy for diffuse B-cell lymphoma: immunohistochemical study. Clin Cancer Res. 3(12 Pt 1):2211–2216.
   PubMed Web of Science ®Google Scholar
• Ohshima Y, Tsukimoto M, Takenouchi T, Harada H, Suzuki A, Sato M, Kitani H, Kojima S. 2010. gamma-Irradiation induces P2X(7) receptor-dependent ATP release from B16 melanoma cells. Biochim Biophys Acta. 1800(1):40–46.
   PubMed Web of Science ®Google Scholar
• Oikawa T, Takahashi H, Ishikawa T, Hokari A, Otsuki N, Azuma M, Zeniya M, Tajiri H. 2007. Intrahepatic expression of the co-stimulatory molecules programmed death-1, and its ligands in autoimmune liver disease. Pathol Int. 57(8):485–492.
   PubMed Web of Science ®Google Scholar
• Park HJ, Griffin RJ, Hui S, Levitt SH, Song CW. 2012. Radiation-induced vascular damage in tumors: implications of vascular damage in ablative hypofractionated radiotherapy (SBRT and SRS). Radiat Res. 177(3):311–327.
   PubMed Web of Science ®Google Scholar
• Patel SP, Kurzrock R. 2015. PD-L1 expression as a predictive biomarker in cancer immunotherapy. Mol Cancer Ther. 14(4):847–856.
   PubMed Web of Science ®Google Scholar
• Paulos CM, Kaiser A, Wrzesinski C, Hinrichs CS, Cassard L, Boni A, Muranski P, Sanchez-Perez L, Palmer DC, Yu Z, et al. 2007. Toll-like receptors in tumor immunotherapy. Clin Cancer Res. 13(18 Pt 1):5280–5289.
   PubMed Web of Science ®Google Scholar
• Philippou Y, Sjoberg HT, Murphy E, Alyacoubi S, Jones KI, Gordon-Weeks AN, Phyu S, Parkes EE, Gillies McKenna W, Lamb AD, et al. 2020. Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model. Br J Cancer. 123(7):1089–1100.
   PubMed Web of Science ®Google Scholar
• Pitroda SP, Stack ME, Liu GF, Song SS, Chen L, Liang H, Parekh AD, Huang X, Roach P, Posner MC, et al. 2018. JAK2 inhibitor SAR302503 abrogates PD-L1 expression and targets therapy-resistant non-small cell lung cancers. Mol Cancer Ther. 17(4):732–739.
   PubMed Web of Science ®Google Scholar
• Quarmby S, Hunter RD, Kumar S. 2000. Irradiation induced expression of CD31, ICAM-1 and VCAM-1 in human microvascular endothelial cells. Anticancer Res. 20(5B):3375–3381.
   PubMed Web of Science ®Google Scholar
• Ramey SJ, Balise R, Ritch C, Punnen S, Ishkanian AS, Pollack A, Abramowitz MC. 2015. Immunocompromised patients with prostate cancer treated with external beam radiation: a matched pair analysis. Int J Radiat Oncol Biol Phys. 933(3):E206.
   Google Scholar
• Reits EA, Hodge JW, Herberts CA, Groothuis TA, Chakraborty M, Wansley EK, Camphausen K, Luiten RM, de Ru AH, Neijssen J, et al. 2006. Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. J Exp Med. 203(5):1259–1271.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Ruiz ME, Garasa S, Rodriguez I, Solorzano JL, Barbes B, Yanguas A, Teijeira A, Etxeberria I, Aristu JJ, Halin C, et al. 2017. Intercellular adhesion molecule-1 and vascular cell adhesion molecule are induced by ionizing radiation on lymphatic endothelium. Int J Radiat Oncol Biol Phys. 97(2):389–400.
   PubMed Web of Science ®Google Scholar
• Roninson IB. 2003. Tumor cell senescence in cancer treatment. Cancer Res. 63(11):2705–2715.
   PubMed Web of Science ®Google Scholar
• Rückert M, Deloch L, Frey B, Schlücker E, Fietkau R, Gaipl US. 2021. Combinations of radiotherapy with vaccination and immune checkpoint inhibition differently affect primary and abscopal tumor growth and the tumor microenvironment. Cancers (Basel). 13(4):714.
   PubMed Web of Science ®Google Scholar
• Rycaj K, Tang DG. 2014. Cancer stem cells and radioresistance. Int J Radiat Biol. 90(8):615–621.
   PubMed Web of Science ®Google Scholar
• Santin AD, Hermonat PL, Ravaggi A, Chiriva-Internati M, Hiserodt JC, Pecorelli S, Parham GP. 1998. Effects of retinoic acid combined with irradiation on the expression of major histocompatibility complex molecules and adhesion/costimulation molecules ICAM-1 in human cervical cancer. Gynecol Oncol. 70(2):195–201.
   PubMed Web of Science ®Google Scholar
• Santin AD, Hiserodt JC, DiSaia PJ, Pećorelli S, Granger GA. 1996. Differential effects of high-dose gamma irradiation on the production of transforming growth factor-beta in fresh and established human ovarian cancer. Gynecol Oncol. 61(3):403–408.
   PubMed Web of Science ®Google Scholar
• Santin AD, Rose GS, Hiserodt JC, Fruehauf J, Eck LM, Garcia RI, Schranz V, Disaia PJ, Pecorelli S, Granger GA. 1996. Effects of cytokines combined with high-dose gamma irradiation on the expression of major histocompatibility complex molecules and intercellular adhesion molecule-1 in human ovarian cancers. Int J Cancer. 65(5):688–694.
   PubMed Web of Science ®Google Scholar
• Sato H, Suzuki Y, Ide M, Katoh T, Noda SE, Ando K, Oike T, Yoshimoto Y, Okonogi N, Mimura K, et al. 2014. HLA class I expression and its alteration by preoperative hyperthermo-chemoradiotherapy in patients with rectal cancer. PLoS One. 9(9):e108122.
   PubMed Web of Science ®Google Scholar
• Schildkopf P, Frey B, Ott OJ, Rubner Y, Multhoff G, Sauer R, Fietkau R, Gaipl US. 2011. Radiation combined with hyperthermia induces HSP70-dependent maturation of dendritic cells and release of pro-inflammatory cytokines by dendritic cells and macrophages. Radiother Oncol. 101(1):109–115.
   PubMed Web of Science ®Google Scholar
• Schnurr M, Then F, Galambos P, Scholz C, Siegmund B, Endres S, Eigler A. 2000. Extracellular ATP and TNF-alpha synergize in the activation and maturation of human dendritic cells. J Immunol. 165(8):4704–4709.
   PubMed Web of Science ®Google Scholar
• Schreiber RD, Old LJ, Smyth MJ. 2011. Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science. 331(6024):1565–1570.
   PubMed Web of Science ®Google Scholar
• Segura E, Amigorena S. 2015. Cross-presentation in mouse and human dendritic cells. Adv Immunol. 127:1–31.
   PubMed Web of Science ®Google Scholar
• Sek K, Mølck C, Stewart GD, Kats L, Darcy PK, Beavis PA. 2018. Targeting adenosine receptor signaling in cancer immunotherapy. Int J Mol Sci. 19(12):3837.
   PubMed Web of Science ®Google Scholar
• Seo A, Ishikawa F, Nakano H, Nakazaki H, Kobayashi K, Kakiuchi T. 1999. Enhancement of B7-1 (CD80) expression on B-lymphoma cells by irradiation. Immunology. 96(4):642–648.
   PubMed Web of Science ®Google Scholar
• Sharma A, Bode B, Wenger RH, Lehmann K, Sartori AA, Moch H, Knuth A, Boehmer L, Broek M. 2011. γ-Radiation promotes immunological recognition of cancer cells through increased expression of cancer-testis antigens in vitro and in vivo. PLoS One. 6(11):e28217.
   PubMed Web of Science ®Google Scholar
• Sheard MA, Vojtesek B, Janakova L, Kovarik J, Zaloudik J. 1997. Up-regulation of Fas (CD95) in human p53wild-type cancer cells treated with ionizing radiation. Int J Cancer. 73(5):757–762.
   PubMed Web of Science ®Google Scholar
• Shen MJ, Xu LJ, Yang L, Tsai Y, Keng PC, Chen Y, Lee SO, Chen Y. 2017. Radiation alters PD-L1/NKG2D ligand levels in lung cancer cells and leads to immune escape from NK cell cytotoxicity via IL-6-MEK/Erk signaling pathway. Oncotarget. 8(46):80506–80520.
   PubMedGoogle Scholar
• Sikic BI, Lakhani N, Patnaik A, Shah SA, Chandana SR, Rasco D, Colevas AD, O'Rourke T, Narayanan S, Papadopoulos K, et al. 2019. First-in-human, first-in-class phase I trial of the anti-CD47 antibody Hu5F9-G4 in patients with advanced cancers. J Clin Oncol. 37(12):946–953.
   PubMed Web of Science ®Google Scholar
• Símová J, Reinis M, Sobota V, Capková J, Bubeník J, Jandlová T. 2000. Irradiation of genetically modified plasmacytoma vaccines results in upregulation of CD80 molecule expression, IL-2 production and higher therapeutic efficacy of the vaccines. Folia Biol (Praha). 46(1):11–15.
   PubMed Web of Science ®Google Scholar
• Sivridis E, Giatromanolaki A, Koukourakis MI. 2005. Proliferating fibroblasts at the invading tumour edge of colorectal adenocarcinomas are associated with endogenous markers of hypoxia, acidity, and oxidative stress. J Clin Pathol. 58(10):1033–1038.
   PubMed Web of Science ®Google Scholar
• Snyder AR, Morgan WF. 2004. Gene expression profiling after irradiation: clues to understanding acute and persistent responses? Cancer Metastasis Rev. 23(3–4):259–268.
   PubMed Web of Science ®Google Scholar
• So EC, Khaladj-Ghom A, Ji Y, Amin J, Song Y, Burch E, Zhou H, Sun H, Chen S, Bentzen S, et al. 2019. NK cell expression of Tim-3: first impressions matter. Immunobiology. 224(3):362–370.
   PubMed Web of Science ®Google Scholar
• Soltani S, Mahmoudi M, Farhadi E. 2021. Dendritic cells currently under the spotlight; classification and subset based upon new markers. Immunol Invest. 50(6):646–661.
   PubMed Web of Science ®Google Scholar
• Soto-Pantoja DR, Kaur S, Roberts DD. 2015. CD47 signaling pathways controlling cellular differentiation and responses to stress. Crit Rev Biochem Mol Biol. 50(3):212–230.
   PubMed Web of Science ®Google Scholar
• Soto-Pantoja DR, Terabe M, Ghosh A, Ridnour LA, DeGraff WG, Wink DA, Berzofsky JA, Roberts DD. 2014. CD47 in the tumor microenvironment limits cooperation between antitumor T-cell immunity and radiotherapy. Cancer Res. 74(23):6771–6783.
   PubMed Web of Science ®Google Scholar
• Spies T, Bresnahan M, Bahram S, Arnold D, Blanck G, Mellins E, Pious D, DeMars R. 1990. A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway. Nature. 348(6303):744–747.
   PubMed Web of Science ®Google Scholar
• Stack BH, McSwan N, Stirling JM, Hole DJ, Spilg WG, McHattie I, Elliott JA, Gillis CR, Turner MA, White RG. 1982. Autologous x-irradiated tumour cells and percutaneous BCG in operable lung cancer. Thorax. 37(8):588–593.
   PubMed Web of Science ®Google Scholar
• Stone HB, Peters LJ, Milas L. 1979. Effect of host immune capability on radiocurability and subsequent transplantability of a murine fibrosarcoma. J Natl Cancer Inst. 63(5):1229–1235.
   PubMedGoogle Scholar
• Sugihara T, Murano H, Nakamura M, Ichinohe K, Tanaka K. 2011. Activation of interferon-stimulated genes by gamma-ray irradiation independently of the ataxia telangiectasia mutated-p53 pathway. Mol Cancer Res. 9(4):476–484.
   PubMed Web of Science ®Google Scholar
• Suit HD, Kastelan A. 1970. Immunologic status of host and response of a methylcholanthrene-induced sarcoma to local x-irradiation. Cancer. 26(1):232–238.
   PubMed Web of Science ®Google Scholar
• Suit HD, Zietman A, Tomkinson K, Ramsay J, Gerweck L, Sedlacek R. 1990. Radiation response of xenografts of a human squamous cell carcinoma and a glioblastoma multiforme: a progress report. Int J Radiat Oncol Biol Phys. 18(2):365–373.
   PubMed Web of Science ®Google Scholar
• Sun GY, Wang SL, Song YW, Jin J, Wang WH, Liu YP, Ren H, Fang H, Tang Y, Zhao XR, et al. 2020. Radiation-induced lymphopenia predicts poorer prognosis in patients with breast cancer: a post hoc analysis of a randomized controlled trial of postmastectomy hypofractionated radiation therapy. Int J Radiat Oncol Biol Phys. 108(1):277–285.
   PubMed Web of Science ®Google Scholar
• Sun Y, Wang Y, Zhao J, Gu M, Giscombe R, Lefvert AK, Wang X. 2006. B7-H3 and B7-H4 expression in non-small-cell lung cancer. Lung Cancer. 53(2):143–151.
   PubMed Web of Science ®Google Scholar
• Takenaka W, Takahashi Y, Tamari K, Minami K, Katsuki S, Seo Y, Isohashi F, Koizumi M, Ogawa K. 2020. Radiation dose escalation is crucial in anti-CTLA-4 antibody therapy to enhance local and distant antitumor effect in murine osteosarcoma. Cancers (Basel). 12(6):1546.
   PubMed Web of Science ®Google Scholar
• Tanji N, Kikugawa T, Ochi T, Taguchi S, Sato H, Sato T, Sugahara T, Hamada H, Asai S, Matsumoto A. 2015. Circulating cytokine levels in patients with prostate cancer: effects of neoadjuvant hormonal therapy and external-beam radiotherapy. Anticancer Res. 35(6):3379–3383.
   PubMed Web of Science ®Google Scholar
• Tauriello DVF, Palomo-Ponce S, Stork D, Berenguer-Llergo A, Badia-Ramentol J, Iglesias M, Sevillano M, Ibiza S, Cañellas A, Hernando-Momblona X, et al. 2018. TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis. Nature. 554(7693):538–543.
   PubMed Web of Science ®Google Scholar
• Teresa Pinto A, Laranjeiro Pinto M, Patrícia Cardoso A, Monteiro C, Teixeira Pinto M, Filipe Maia A, Castro P, Figueira R, Monteiro A, Marques M, et al. 2016. Ionizing radiation modulates human macrophages towards a pro-inflammatory phenotype preserving their pro-invasive and pro-angiogenic capacities. Sci Rep. 6:18765.
   PubMed Web of Science ®Google Scholar
• Timosenko E, Hadjinicolaou AV, Cerundolo V. 2017. Modulation of cancer-specific immune responses by amino acid degrading enzymes. Immunotherapy. 9(1):83–97.
   PubMed Web of Science ®Google Scholar
• Tinhofer I, Marschitz I, Kos M, Henn T, Egle A, Villunger A, Greil R. 1998. Differential sensitivity of CD4+ and CD8+ T lymphocytes to the killing efficacy of Fas (Apo-1/CD95) ligand + tumor cells in B chronic lymphocytic leukemia. Blood. 91(11):4273–4281.
   PubMed Web of Science ®Google Scholar
• Tommelein J, De Vlieghere E, Verset L, Melsens E, Leenders J, Descamps B, Debucquoy A, Vanhove C, Pauwels P, Gespach CP, et al. 2018. Radiotherapy-activated cancer-associated fibroblasts promote tumor progression through paracrine IGF1R activation. Cancer Res. 78(3):659–670.
   PubMed Web of Science ®Google Scholar
• Tseng YD, Nguyen MH, Baker K, Cook M, Redman M, Lachance K, Bhatia S, Liao JJ, Apisarnthanarax S, Nghiem PT, et al. 2018. Effect of patient immune status on the efficacy of radiation therapy and recurrence-free survival among 805 patients with Merkel cell carcinoma. Int J Radiat Oncol Biol Phys. 102(2):330–339.
   PubMed Web of Science ®Google Scholar
• Tsoutsou PG, Koukourakis MI. 2006. Radiation pneumonitis and fibrosis: mechanisms underlying its pathogenesis and implications for future research. Int J Radiat Oncol Biol Phys. 66(5):1281–1293.
   PubMed Web of Science ®Google Scholar
• Tubiana M, Frindel E, Croizat H, Parmentier C. 1979. Effects of radiations on bone marrow. Pathol Biol (Paris). 27(6):326–334.
   PubMedGoogle Scholar
• Uchida A, Mizutani Y, Nagamuta M, Ikenaga M. 1989. Effects of X-ray irradiation on natural killer (NK) cell system. I. Elevation of sensitivity of tumor cells and lytic function of NK cells. Immunopharmacol Immunotoxicol. 11(2–3):507–519.
   PubMed Web of Science ®Google Scholar
• Ullrich E, Koch J, Cerwenka A, Steinle A. 2013. New prospects on the NKG2D/NKG2DL system for oncology. Oncoimmunology. 2(10):e26097.
   PubMed Web of Science ®Google Scholar
• Uno M, Otsuki T, Yata K, Fujii T, Sakaguchi H, Akisada T, Hiratsuka J, Imajo Y, Harada T. 2002. Participation of Fas-mediated apoptotic pathway in KB, a human head and neck squamous cell carcinoma cell line, after irradiation. Int J Oncol. 20(3):617–622.
   PubMed Web of Science ®Google Scholar
• Vanpouille-Box C, Alard A, Aryankalayil MJ, Sarfraz Y, Diamond JM, Schneider RJ, Inghirami G, Coleman CN, Formenti SC, Demaria S. 2017. DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity. Nat Commun. 8:15618.
   PubMed Web of Science ®Google Scholar
• Varga G, Balkow S, Wild MK, Stadtbaeumer A, Krummen M, Rothoeft T, Higuchi T, Beissert S, Wethmar K, Scharffetter-Kochanek K, et al. 2007. Active MAC-1 (CD11b/CD18) on DCs inhibits full T-cell activation. Blood. 109(2):661–669.
   PubMed Web of Science ®Google Scholar
• Venkatesulu BP, Mallick S, Lin SH, Krishnan S. 2018. A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors. Crit Rev Oncol Hematol. 123:42–51.
   PubMed Web of Science ®Google Scholar
• Ventelä S, Sittig E, Mannermaa L, Mäkelä JA, Kulmala J, Löyttyniemi E, Strauss L, Cárpen O, Toppari J, Grénman R, et al. 2015. CIP2A is an Oct4 target gene involved in head and neck squamous cell cancer oncogenicity and radioresistance. Oncotarget. 6(1):144–158.
   PubMedGoogle Scholar
• Vereecque R, Buffenoir G, Gonzalez R, Cambier N, Hetuin D, Bauters F, Fenaux P, Quesnel B. 2000. gamma-ray irradiation induces B7.1 expression in myeloid leukaemic cells. Br J Haematol. 108(4):825–831.
   PubMed Web of Science ®Google Scholar
• Vermeer DW, Spanos WC, Vermeer PD, Bruns AM, Lee KM, Lee JH. 2013. Radiation-induced loss of cell surface CD47 enhances immune-mediated clearance of human papillomavirus-positive cancer. Int J Cancer. 133(1):120–129.
   PubMed Web of Science ®Google Scholar
• Vermorken JB, Claessen AM, van Tinteren H, Gall HE, Ezinga R, Meijer S, Scheper RJ, Meijer CJ, Bloemena E, Ransom JH, et al. 1999. Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial. Lancet. 353(9150):345–350.
   PubMed Web of Science ®Google Scholar
• Viel S, Marçais A, Guimaraes FS, Loftus R, Rabilloud J, Grau M, Degouve S, Djebali S, Sanlaville A, Charrier E, et al. 2016. TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway. Sci Signal. 9(415):ra19.
   PubMed Web of Science ®Google Scholar
• Voos P, Fuck S, Weipert F, Babel L, Tandl D, Meckel T, Hehlgans S, Fournier C, Moroni A, Rödel F, et al. 2018. Ionizing radiation induces morphological changes and immunological modulation of jurkat cells. Front Immunol. 9:922.
   PubMed Web of Science ®Google Scholar
• Wan S, Pestka S, Jubin RG, Lyu YL, Tsai YC, Liu LF. 2012. Chemotherapeutics and radiation stimulate MHC class I expression through elevated interferon-beta signaling in breast cancer cells. PLoS One. 7(3):e32542.
   PubMed Web of Science ®Google Scholar
• Wang X, Schoenhals JE, Li A, Valdecanas DR, Ye H, Zang F, Tang C, Tang M, Liu CG, Liu X, et al. 2017. Suppression of type I IFN signaling in tumors mediates resistance to anti-PD-1 treatment that can be overcome by radiotherapy. Cancer Res. 77(4):839–850.
   PubMed Web of Science ®Google Scholar
• Waring P, Müllbacher A. 1999. Cell death induced by the Fas/Fas ligand pathway and its role in pathology. Immunol Cell Biol. 77(4):312–317.
   PubMed Web of Science ®Google Scholar
• Wasserman J, Petrini B, Wolk G, Vedin I, Glas U, Blomgren H, Ekre HP, Strannegård O. 1991. Cytokine release from mononuclear cells in patients irradiated for breast cancer. Anticancer Res. 11(1):461–464.
   PubMed Web of Science ®Google Scholar
• Weiskopf K. 2017. Cancer immunotherapy targeting the CD47/SIRPα axis. Eur J Cancer. 76:100–109.
   PubMed Web of Science ®Google Scholar
• White EC, Khodayari B, Erickson KT, Lien WW, Hwang-Graziano J, Rao AR. 2017. Comparison of toxicity and treatment outcomes in HIV-positive versus HIV-negative patients with squamous cell carcinoma of the anal canal. Am J Clin Oncol. 40(4):386–392.
   PubMed Web of Science ®Google Scholar
• Widau RC, Parekh AD, Ranck MC, Golden DW, Kumar KA, Sood RF, Pitroda SP, Liao Z, Huang X, Darga TE, et al. 2014. RIG-I-like receptor LGP2 protects tumor cells from ionizing radiation. Proc Natl Acad Sci USA. 111(4):E484–E491.
   PubMed Web of Science ®Google Scholar
• Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA. 1995. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity. 3(6):673–682.
   PubMed Web of Science ®Google Scholar
• Wu Q, Allouch A, Paoletti A, Leteur C, Mirjolet C, Martins I, Voisin L, Law F, Dakhli H, Mintet E, et al. 2017. NOX2-dependent ATM kinase activation dictates pro-inflammatory macrophage phenotype and improves effectiveness to radiation therapy. Cell Death Differ. 24(9):1632–1644.
   PubMed Web of Science ®Google Scholar
• Wu N, Jin SZ, Pan XN, Liu SZ. 2008. Increase in efficacy of cancer radiotherapy by combination with whole-body low dose irradiation. Int J Radiat Biol. 84(3):201–210.
   PubMed Web of Science ®Google Scholar
• Wu CT, Lin WY, Chang YH, Chen WC, Chen MF. 2017. Impact of CD44 expression on radiation response for bladder cancer. J Cancer. 8(7):1137–1144.
   PubMed Web of Science ®Google Scholar
• Xuan W, Qu Q, Zheng B, Xiong S, Fan GH. 2015. The chemotaxis of M1 and M2 macrophages is regulated by different chemokines. J Leukoc Biol. 97(1):61–69.
   PubMed Web of Science ®Google Scholar
• Yoshimoto Y, Oike T, Okonogi N, Suzuki Y, Ando K, Sato H, Noda SE, Isono M, Mimura K, Kono K, et al. 2015. Carbon-ion beams induce production of an immune mediator protein, high mobility group box 1, at levels comparable with X-ray irradiation. J Radiat Res. 56(3):509–514.
   PubMed Web of Science ®Google Scholar
• Young NT, Bunce M, Morris PJ, Welsh KI. 1997. Killer cell inhibitory receptor interactions with HLA class I molecules: implications for alloreactivity and transplantation. Hum Immunol. 52(1):1–11.
   PubMed Web of Science ®Google Scholar
• Zhang H, Lu H, Xiang L, Bullen JW, Zhang C, Samanta D, Gilkes DM, He J, Semenza GL. 2015. HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells. Proc Natl Acad Sci USA. 112(45):E6215–E6223.
   PubMed Web of Science ®Google Scholar
• Zhao K, Jiang L, Si Y, Zhou S, Huang Z, Meng X. 2022. TIGIT blockade enhances tumor response to radiotherapy via a CD103 + dendritic cell-dependent mechanism. Cancer Immunol Immunother. doi: 10.1007/s00262-022-03227-z.
   Web of Science ®Google Scholar
• Zheng W, Ranoa DRE, Huang X, Hou Y, Yang K, Poli EC, Beckett MA, Fu YX, Weichselbaum RR. 2020. RIG-I-Like receptor LGP2 is required for tumor control by radiotherapy. Cancer Res. 80(24):5633–5641.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Zhao J, Hu K, Hou X, Sun X, Pan X, Wang X, Li N, Yang Z, Zhang F, et al. 2021. Single high-dose radiation enhances dendritic cell homing and T cell priming by promoting reactive oxygen species-induced cytoskeletal reorganization. Int J Radiat Oncol Biol Phys. 109(1):95–108.
   PubMed Web of Science ®Google Scholar
• Ziani L, Chouaib S, Thiery J. 2018. Alteration of the antitumor immune response by cancer-associated fibroblasts. Front Immunol. 9:414.
   PubMed Web of Science ®Google Scholar
• Zitvogel L, Galluzzi L, Kepp O, Smyth MJ, Kroemer G. 2015. Type I interferons in anticancer immunity. Nat Rev Immunol. 15(7):405–414.
   PubMed Web of Science ®Google Scholar
• Zölzer F, Hillebrandt S, Streffer C. 1995. Radiation induced G1-block and p53 status in six human cell lines. Radiother Oncol. 37(1):20–28.
   PubMed Web of Science ®Google Scholar